Login / Signup

mEPE-score: a comprehensive grading system for predicting pathologic extraprostatic extension of prostate cancer at multiparametric magnetic resonance imaging.

Marco GattiRiccardo FalettiFrancesco GentileEnrico SoncinGiorgio CallerisAlberto FornariMarco OderdaAlessandro SerafiniGiulio Antonino StrazzarinoElena VissioLaura BergamascoStefano CirilloMauro Giulio PapottiPaolo GonteroPaolo Fonio
Published in: European radiology (2022)
• Individual PI-RADS v2.1 mpMRI features had poor sensitivities ranging from 0.08 (0.00-0.15) to 0.71 (0.59-0.83), whereas Sp ranged from 0.68 (0.58-0.79) to 1.00. • mEPE-score is an all-inclusive score for the assessment of pEPE with excellent discriminating ability (i.e., AUC > 0.8) and Se = 0.82, Sp = 0.77, PPV = 0.74, and NPV = 0.84 with a threshold of 3. • The diagnostic performance of the expert reader and beginner reader with pEPE-score was comparable (p = 0.32).
Keyphrases
  • prostate cancer
  • magnetic resonance imaging
  • computed tomography
  • radical prostatectomy
  • squamous cell carcinoma
  • radiation therapy
  • neoadjuvant chemotherapy
  • magnetic resonance
  • clinical practice
  • contrast enhanced